Home/Filings/4/A/0001140361-25-013563
4/A//SEC Filing

Tignor Michael Brent 4/A

Accession 0001140361-25-013563

CIK 0000009326other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 6:43 PM ET

Size

11.1 KB

Accession

0001140361-25-013563

Insider Transaction Report

Form 4/AAmended
Period: 2025-02-12
Tignor Michael Brent
SVP & Chief HR Officer
Transactions
  • Award

    Common Stock

    2025-02-12+1,2908,072 total
  • Award

    Common Stock

    2025-02-13+2,20710,279 total
  • Tax Payment

    Common Stock

    2025-02-13$163.14/sh1,156$188,5909,123 total
  • Award

    Stock Option

    2025-02-12+4,2004,200 total
    Exercise: $159.18Exp: 2035-02-12Common Stock (4,200 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,307
Footnotes (4)
  • [F1]Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
  • [F2]Represents the vesting of performance stock units (includes 36 dividend equivalent shares) for the 2022-2024 performance period.
  • [F3]1,156 of the 2,207 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
  • [F4]Options vest 20% Year 1; 40% Year 2; and 40% Year 3.

Documents

1 file

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001908271

Filing Metadata

Form type
4/A
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 6:43 PM ET
Size
11.1 KB